With this acquisition, the medical testing giant gains a powerful tool that should help it turn data into healthcare progress.
News & Analysis: Quest Diagnostics
The company is coming off a strong third quarter, and investors can expect to see its year-end results toward the end of this month.
The diagnostics information services company beat expectations on both the top and bottom lines.
The laboratory services company beat Wall Street estimates despite reporting only modest revenue growth and another earnings decline.
The diagnostics information services company provided an upside surprise on both the top and bottom lines.
A positive Q1 update provided a nice boost to the diagnostics information services stock.
Quest Diagnostics' Drug Testing Index highlights a potentially worrisome trend.
DGX earnings call for the period ending December 31, 2018.
Even as the market largely recovered from early losses, these stocks still gave up ground. Find out why.
Lower full-year 2018 revenue and earnings estimates cause investors to sour on the diagnostics services provider.